Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew P Martin

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nature Communications|April 14, 2015
CDK1 structures reveal conserved and unique features of the essential cell cycle CDKNicholas R Brown, Svitlana Korolchuk, Mathew P Martin, et al.
Journal of Proteome Research|July 13, 2023
Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome ProfilingAmy L George, Frances R Sidgwick, Jessica E Watt, et al.
Cell Chemical Biology|November 26, 2018
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK InhibitionDaniel J Wood, Svitlana Korolchuk, Natalie J Tatum, et al.
Bioorganic & Medicinal Chemistry|July 7, 2023
Conformational study into N-alkyl-N'-aryl ureas to inform drug discoveryHannah L Stewart, Marta Bon, Corinne Wills, et al.
Molecules (Basel, Switzerland)|January 22, 2015
Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2Sanne H Olesen, Donna J Ingles, Jin-Yi Zhu, et al.
ACS Chemical Biology|February 27, 2014
Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitorsStuart W J Ember, Jin-Yi Zhu, Sanne H Olesen, et al.
Cancer Research|August 1, 2012
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancerRonil A Patel, Kara D Forinash, Roberta Pireddu, et al.
ACS Chemical Biology|January 18, 2012
A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora AMathew P Martin, Jin-Yi Zhu, Harshani R Lawrence, et al.
Journal of Medicinal Chemistry|August 10, 2017
Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule InhibitorsJin-Yi Zhu, Rebecca A Cuellar, Norbert Berndt, et al.
Medchemcomm|January 1, 2013
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)Roberta Pireddu, Kara D Forinash, Nan N Sun, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nature Communications|April 14, 2015
CDK1 structures reveal conserved and unique features of the essential cell cycle CDKNicholas R Brown, Svitlana Korolchuk, Mathew P Martin, et al.
Journal of Proteome Research|July 13, 2023
Comparison of Quantitative Mass Spectrometric Methods for Drug Target Identification by Thermal Proteome ProfilingAmy L George, Frances R Sidgwick, Jessica E Watt, et al.
Cell Chemical Biology|November 26, 2018
Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK InhibitionDaniel J Wood, Svitlana Korolchuk, Natalie J Tatum, et al.
Bioorganic & Medicinal Chemistry|July 7, 2023
Conformational study into N-alkyl-N'-aryl ureas to inform drug discoveryHannah L Stewart, Marta Bon, Corinne Wills, et al.
Molecules (Basel, Switzerland)|January 22, 2015
Stability of the human Hsp90-p50Cdc37 chaperone complex against nucleotides and Hsp90 inhibitors, and the influence of phosphorylation by casein kinase 2Sanne H Olesen, Donna J Ingles, Jin-Yi Zhu, et al.
ACS Chemical Biology|February 27, 2014
Acetyl-lysine binding site of bromodomain-containing protein 4 (BRD4) interacts with diverse kinase inhibitorsStuart W J Ember, Jin-Yi Zhu, Sanne H Olesen, et al.
Cancer Research|August 1, 2012
RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancerRonil A Patel, Kara D Forinash, Roberta Pireddu, et al.
ACS Chemical Biology|January 18, 2012
A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora AMathew P Martin, Jin-Yi Zhu, Harshani R Lawrence, et al.
Journal of Medicinal Chemistry|August 10, 2017
Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule InhibitorsJin-Yi Zhu, Rebecca A Cuellar, Norbert Berndt, et al.
Medchemcomm|January 1, 2013
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2)Roberta Pireddu, Kara D Forinash, Nan N Sun, et al.
Pageof 4